Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |